Biogen’s antibody lupus treatment shows mid-stage promiseR&D, TherapeuticsBiogen announced that its mid-stage monoclonal antibody, litifilimab, is showing promise in reducing joint pain related to systemic lupus erythematosus (SLE) lupus. Read more September 9, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/03/Appeals-Court-Upholds-Decision-for-Mylan-Generic-of-Biogen-MS-Drug-BioSpace-3-17-22.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-09-09 12:07:152022-09-09 12:07:15Biogen’s antibody lupus treatment shows mid-stage promise
